Arca
Skip to content

Mylan Institutional

Generic drug maker in United States, part of Viatris. FDA records under 5 spellings of its name, each linked to the record. See the Viatris group view.

  • Drug recalls: 46
  • Drug applications: 34

Records by Year

Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date

Latest Records

Newest first across sources; each opens the record
DateRecordSource
Feb 1, 2019Levoleucovorin Injection, 250 mg/25 mL, (10 mg/mL), 25 mL Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, ILClass I · Presence of Particulate Matter: particulate matter identified as copper saltsDrug recalls

Names and Identifiers

Appears as
MYLAN INSTITUTIONALMylan Institutional, Inc. (d.b.a. UDL Laboratories)Mylan Institutional LLCMylan Institutional, Inc.Mylan Institutional Inc

Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.